Futura Medical Expands Oversubscribed Retail Fundraising to £200,000, Raising £1.8 Million in Total Capital

Futura Medical Expands Oversubscribed Retail Fundraising to £200,000, Raising £1.8 Million in Total Capital →

Futura Medical plc (AIM: FUM), the consumer healthcare company behind the erectile dysfunction gel Eroxon® , has revealed that its Retail Offer on the BookBuild platform was heavily oversubscribed, leading to an increase in the raise from t…